ABVC BioPharma (ABVC) Competitors $2.83 -0.25 (-8.12%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.83 0.00 (0.00%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABVC vs. LFCR, RNAC, MREO, CTNM, TVRD, GALT, LXEO, VOR, DBVT, and JBIOShould you be buying ABVC BioPharma stock or one of its competitors? The main competitors of ABVC BioPharma include Lifecore Biomedical (LFCR), Cartesian Therapeutics (RNAC), Mereo BioPharma Group (MREO), Contineum Therapeutics (CTNM), Tvardi Therapeutics (TVRD), Galectin Therapeutics (GALT), Lexeo Therapeutics (LXEO), Vor Biopharma (VOR), DBV Technologies (DBVT), and Jade Biosciences (JBIO). These companies are all part of the "pharmaceutical products" industry. ABVC BioPharma vs. Its Competitors Lifecore Biomedical Cartesian Therapeutics Mereo BioPharma Group Contineum Therapeutics Tvardi Therapeutics Galectin Therapeutics Lexeo Therapeutics Vor Biopharma DBV Technologies Jade Biosciences ABVC BioPharma (NASDAQ:ABVC) and Lifecore Biomedical (NASDAQ:LFCR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment. Does the media favor ABVC or LFCR? In the previous week, ABVC BioPharma had 1 more articles in the media than Lifecore Biomedical. MarketBeat recorded 3 mentions for ABVC BioPharma and 2 mentions for Lifecore Biomedical. Lifecore Biomedical's average media sentiment score of 1.71 beat ABVC BioPharma's score of 0.63 indicating that Lifecore Biomedical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABVC BioPharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifecore Biomedical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation and earnings, ABVC or LFCR? ABVC BioPharma has higher earnings, but lower revenue than Lifecore Biomedical. ABVC BioPharma is trading at a lower price-to-earnings ratio than Lifecore Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$510K130.62-$4.90M-$0.17-16.65Lifecore Biomedical$128.87M2.21-$38.72M-$1.31-5.81 Which has more risk and volatility, ABVC or LFCR? ABVC BioPharma has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Comparatively, Lifecore Biomedical has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Is ABVC or LFCR more profitable? Lifecore Biomedical has a net margin of -31.70% compared to ABVC BioPharma's net margin of -963.46%. ABVC BioPharma's return on equity of -46.76% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-963.46% -46.76% -23.02% Lifecore Biomedical -31.70%-846.51%-13.03% Do analysts rate ABVC or LFCR? Lifecore Biomedical has a consensus price target of $8.00, suggesting a potential upside of 5.12%. Given Lifecore Biomedical's stronger consensus rating and higher possible upside, analysts clearly believe Lifecore Biomedical is more favorable than ABVC BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ABVC BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lifecore Biomedical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders & institutionals hold more shares of ABVC or LFCR? 11.4% of ABVC BioPharma shares are owned by institutional investors. Comparatively, 83.4% of Lifecore Biomedical shares are owned by institutional investors. 17.1% of ABVC BioPharma shares are owned by insiders. Comparatively, 32.2% of Lifecore Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryLifecore Biomedical beats ABVC BioPharma on 11 of the 16 factors compared between the two stocks. Get ABVC BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABVC vs. The Competition Export to ExcelMetricABVC BioPharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$66.62M$3.08B$5.69B$9.74BDividend YieldN/A2.28%6.64%4.48%P/E Ratio-16.6520.9283.1926.59Price / Sales130.62352.35515.16159.07Price / CashN/A43.5325.6628.92Price / Book47.179.7811.766.08Net Income-$4.90M-$54.01M$3.27B$265.93M7 Day Performance-3.41%0.10%1.13%0.36%1 Month Performance2.91%8.52%8.30%5.58%1 Year Performance319.07%7.03%62.26%19.67% ABVC BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABVCABVC BioPharma0.3631 of 5 stars$2.83-8.1%N/A+319.1%$66.62M$510K-16.6530LFCRLifecore Biomedical0.6613 of 5 stars$7.50-1.2%$8.00+6.7%+73.7%$280.58M$128.87M-5.73690RNACCartesian Therapeutics2.3587 of 5 stars$10.78-4.2%$40.00+271.1%-28.0%$280.28M$38.91M-0.2064Positive NewsMREOMereo BioPharma Group1.9907 of 5 stars$1.76+1.1%$7.40+320.5%-63.5%$279.84M$10M-25.1440CTNMContineum Therapeutics3.0853 of 5 stars$9.80-5.7%$22.75+132.1%-46.4%$274.79M$50M-4.4531TVRDTvardi TherapeuticsN/A$29.21+0.0%$64.25+120.0%N/A$273.90MN/A0.0080GALTGalectin Therapeutics2.0226 of 5 stars$4.16+4.0%$6.00+44.2%+58.8%$266.49MN/A-6.509Positive NewsLXEOLexeo Therapeutics2.4343 of 5 stars$4.89+4.9%$15.33+213.6%-58.4%$264.06M$650K-1.5058Positive NewsVORVor Biopharma1.8376 of 5 stars$2.08+1.0%$6.07+191.7%+125.3%$263.50MN/A-1.26140Insider TradeDBVTDBV Technologies3.3012 of 5 stars$9.61-1.8%$14.75+53.5%+112.9%$263.22M$4.15M-2.0180JBIOJade Biosciences2.3189 of 5 stars$8.03+1.6%$16.00+99.3%N/A$262.02MN/A-0.2620 Related Companies and Tools Related Companies Lifecore Biomedical Competitors Cartesian Therapeutics Competitors Mereo BioPharma Group Competitors Contineum Therapeutics Competitors Tvardi Therapeutics Competitors Galectin Therapeutics Competitors Lexeo Therapeutics Competitors Vor Biopharma Competitors DBV Technologies Competitors Jade Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABVC) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredChase, Bank of America, Wells Fargo Preparing for BIG ChangeThanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in Am...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABVC Stock Alerts